The manufacturer of
venlafaxine cautions its use with
SSRIs because of the potential risks of
serotonin syndrome. Cases of this reaction have been reported. Additive antimuscarinic effects have also been seen.
Monitor concurrent use carefully for
symptoms including agitation, confusion and tremor.